These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 20008140)

  • 1. MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema.
    Manner J; Radlwimmer B; Hohenberger P; Mössinger K; Küffer S; Sauer C; Belharazem D; Zettl A; Coindre JM; Hallermann C; Hartmann JT; Katenkamp D; Katenkamp K; Schöffski P; Sciot R; Wozniak A; Lichter P; Marx A; Ströbel P
    Am J Pathol; 2010 Jan; 176(1):34-9. PubMed ID: 20008140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYC amplification in angiosarcomas arising in the setting of chronic lymphedema of morbid obesity.
    Harker D; Jennings M; McDonough P; Mauskar M; Savory S; Hosler GA; Vandergriff T
    J Cutan Pathol; 2017 Jan; 44(1):15-19. PubMed ID: 27686553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYC gene amplification by fluorescence in situ hybridization and MYC protein expression by immunohistochemistry in the diagnosis of cutaneous angiosarcoma: Systematic review and appropriate use criteria.
    Motaparthi K; Lauer SR; Patel RM; Vidal CI; Linos K
    J Cutan Pathol; 2021 Apr; 48(4):578-586. PubMed ID: 33128474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The miR-17-92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification.
    Italiano A; Thomas R; Breen M; Zhang L; Crago AM; Singer S; Khanin R; Maki RG; Mihailovic A; Hafner M; Tuschl T; Antonescu CR
    Genes Chromosomes Cancer; 2012 Jun; 51(6):569-78. PubMed ID: 22383169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study.
    Shon W; Sukov WR; Jenkins SM; Folpe AL
    Mod Pathol; 2014 Apr; 27(4):509-15. PubMed ID: 24091875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical and Fluorescence In Situ Hybridization Analysis of MYC in a Series of 17 Cutaneous Angiosarcomas: A Single-Center Study.
    Requena C; Rubio L; Lavernia J; Machado I; Llombart B; Sanmartín O; Traves V; Guillén C; Cruz J
    Am J Dermatopathol; 2018 May; 40(5):349-354. PubMed ID: 29135507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases.
    Mentzel T; Schildhaus HU; Palmedo G; Büttner R; Kutzner H
    Mod Pathol; 2012 Jan; 25(1):75-85. PubMed ID: 21909081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility of MYC amplification and anti-MYC immunohistochemistry in atypical vascular lesions, primary or radiation-induced mammary angiosarcomas, and primary angiosarcomas of other sites.
    Ginter PS; Mosquera JM; MacDonald TY; D'Alfonso TM; Rubin MA; Shin SJ
    Hum Pathol; 2014 Apr; 45(4):709-16. PubMed ID: 24457083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can c-myc amplification reliably discriminate postradiation from primary angiosarcoma of the breast?
    Laé M; Lebel A; Hamel-Viard F; Asselain B; Trassard M; Sastre X; Kirova YM
    Cancer Radiother; 2015 May; 19(3):168-74. PubMed ID: 25863565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Array CGH analysis identifies two distinct subgroups of primary angiosarcoma of bone.
    Verbeke SL; de Jong D; Bertoni F; Sciot R; Antonescu CR; Szuhai K; Bovée JV
    Genes Chromosomes Cancer; 2015 Feb; 54(2):72-81. PubMed ID: 25231439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.
    Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Singer S; Tap WD; D'Angelo S; Antonescu CR
    Am J Surg Pathol; 2016 May; 40(5):645-55. PubMed ID: 26735859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fully automated dual-color dual-hapten silver in situ hybridization staining for MYC amplification: a diagnostic tool for discriminating secondary angiosarcoma.
    Ko JS; Billings SD; Lanigan CP; Buehler D; Fernandez AP; Tubbs RR
    J Cutan Pathol; 2014 Mar; 41(3):286-92. PubMed ID: 24329959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression.
    Fraga-Guedes C; André S; Mastropasqua MG; Botteri E; Toesca A; Rocha RM; Peradze N; Rotmensz N; Viale G; Veronesi P; Gobbi H
    Breast Cancer Res Treat; 2015 May; 151(1):131-40. PubMed ID: 25893585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations.
    Fernandez AP; Sun Y; Tubbs RR; Goldblum JR; Billings SD
    J Cutan Pathol; 2012 Feb; 39(2):234-42. PubMed ID: 22121953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation-induced breast angiosarcoma with a confirmative feature of c-MYC amplification.
    Tajima S; Mochizuki R; Sugimura H; Hoshi S
    Jpn J Clin Oncol; 2014 Jul; 44(7):702-3. PubMed ID: 24903854
    [No Abstract]   [Full Text] [Related]  

  • 16. Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions.
    Guo T; Zhang L; Chang NE; Singer S; Maki RG; Antonescu CR
    Genes Chromosomes Cancer; 2011 Jan; 50(1):25-33. PubMed ID: 20949568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
    Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of MYC gene amplification is a common feature of radiation-induced sarcomas. Further results from EORTC STBSG TL 01/01.
    Käcker C; Marx A; Mössinger K; Svehla F; Schneider U; Hogendoorn PC; Nielsen OS; Küffer S; Sauer C; Fisher C; Hallermann C; Hartmann JT; Blay JY; Mechtersheimer G; Hohenberger P; Ströbel P
    Genes Chromosomes Cancer; 2013 Jan; 52(1):93-8. PubMed ID: 23012233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYC Analysis by Fluorescent In Situ Hybridization and Immunohistochemistry in Primary Adrenal Angiosarcoma (PAA): a Series of Four Cases.
    Cornejo KM; Hutchinson L; Cyr MS; Nose V; McLaughlin PJ; Iafrate AJ; Sadow PM
    Endocr Pathol; 2015 Dec; 26(4):334-41. PubMed ID: 26223194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYC amplification and polysomy 8 in chondrosarcoma: array comparative genomic hybridization, fluorescent in situ hybridization, and association with outcome.
    Morrison C; Radmacher M; Mohammed N; Suster D; Auer H; Jones S; Riggenbach J; Kelbick N; Bos G; Mayerson J
    J Clin Oncol; 2005 Dec; 23(36):9369-76. PubMed ID: 16361637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.